FIELD: medicine.
SUBSTANCE: composition contains: a. core composition including therapeutically active agent, swelling agent and capillary agent; b. coating composition including water-insoluble polymer and water-soluble polymer.
EFFECT: composition releases therapeutically active agent in pulse mode at preset time.
21 cl, 15 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYSTEM OF SEPARATE MEDICATION DELIVERY | 2002 |
|
RU2351317C2 |
| CONTROLLED-RELEASE FORMULATION | 2006 |
|
RU2385712C2 |
| ORAL PHARMACEUTICAL MEDICINAL FORM WITH DISCRETE RELEASE | 1998 |
|
RU2205028C2 |
| EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF | 2012 |
|
RU2603471C2 |
| PASTILLE DOZED FORM | 2018 |
|
RU2771806C2 |
| TABLET WITH CONTROLLED ALFUZOSIN HYDROCHLORIDE RELEASE | 1997 |
|
RU2183459C2 |
| MEDICINE CONTAINING 3-(3-DIMETHYLAMINE-1-ETHYL-2-METHYLPROPYL) PHENOL WITH PROLONGED RELEASE OF REACTANT | 2002 |
|
RU2325905C2 |
| SOLID OR SEMI-LIQUID TIME-RELEASE DOSAGE FORMS | 2008 |
|
RU2471480C2 |
| NEW PROLONGED COMPOSITIONS FOR PERORAL ADMINISTRATION | 1999 |
|
RU2286766C2 |
| STABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING SUBSTITUTED PYRIDYLSULFINYLBENZIMIDAZOLE | 1998 |
|
RU2216321C2 |
